USD 3.79
(-2.07%)
Year | Inventory | Inventory Growth |
---|---|---|
2023 | 47.61 Million USD | -50.52% |
2022 | 96.23 Million USD | 81.1% |
2021 | 53.13 Million USD | 66.77% |
2020 | 31.86 Million USD | 37.61% |
2019 | 23.15 Million USD | 1.17% |
2018 | 22.88 Million USD | 18.33% |
2017 | 19.34 Million USD | 63.94% |
2016 | 11.79 Million USD | -10.9% |
2015 | 13.24 Million USD | -15.99% |
2014 | 15.76 Million USD | 37.74% |
2013 | 11.44 Million USD | -10.3% |
2012 | 12.75 Million USD | 32.61% |
2011 | 9.62 Million USD | 30.97% |
2010 | 7.34 Million USD | -16.94% |
2009 | 8.84 Million USD | -17.37% |
2008 | 10.7 Million USD | 13.76% |
2007 | 9.4 Million USD | 70.02% |
2006 | 5.53 Million USD | 34.07% |
2005 | 4.12 Million USD | -16.64% |
2004 | 4.95 Million USD | 23.69% |
2003 | 4 Million USD | -2.08% |
2002 | 4.08 Million USD | -8.02% |
2001 | 4.44 Million USD | 197.19% |
2000 | 1.49 Million USD | -0.29% |
1999 | 1.5 Million USD | 36.36% |
1998 | 1.1 Million USD | -15.38% |
1997 | 1.3 Million USD | -83.12% |
1996 | 7.7 Million USD | 450.0% |
1995 | 1.4 Million USD | -17.65% |
1994 | 1.7 Million USD | 70.0% |
1993 | 1 Million USD | 11.11% |
1992 | 900 Thousand USD | -18.18% |
1991 | 1.1 Million USD | 37.5% |
1990 | 800 Thousand USD | 166.67% |
1989 | 300 Thousand USD | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2024 Q2 | 38.25 Million USD | -11.41% |
2024 Q1 | 43.18 Million USD | -9.31% |
2023 Q2 | 73.28 Million USD | -5.06% |
2023 Q3 | 59.26 Million USD | -19.13% |
2023 Q4 | 47.61 Million USD | -19.66% |
2023 FY | 47.61 Million USD | -50.52% |
2023 Q1 | 77.18 Million USD | -19.79% |
2022 Q2 | 71.3 Million USD | 15.87% |
2022 Q3 | 78.8 Million USD | 10.52% |
2022 Q4 | 96.23 Million USD | 22.11% |
2022 Q1 | 61.53 Million USD | 15.8% |
2022 FY | 96.23 Million USD | 81.1% |
2021 FY | 53.13 Million USD | 66.77% |
2021 Q4 | 53.13 Million USD | -0.83% |
2021 Q3 | 53.58 Million USD | 11.24% |
2021 Q2 | 48.17 Million USD | 19.38% |
2021 Q1 | 40.35 Million USD | 26.64% |
2020 Q3 | 30.48 Million USD | 10.04% |
2020 Q2 | 27.7 Million USD | 22.09% |
2020 Q1 | 22.69 Million USD | -1.99% |
2020 FY | 31.86 Million USD | 37.61% |
2020 Q4 | 31.86 Million USD | 4.51% |
2019 FY | 23.15 Million USD | 1.17% |
2019 Q3 | 25.04 Million USD | -2.45% |
2019 Q4 | 23.15 Million USD | -7.53% |
2019 Q1 | 26.21 Million USD | 14.53% |
2019 Q2 | 25.67 Million USD | -2.07% |
2018 Q1 | 20.9 Million USD | 8.09% |
2018 FY | 22.88 Million USD | 18.33% |
2018 Q4 | 22.88 Million USD | 15.02% |
2018 Q3 | 19.89 Million USD | -3.4% |
2018 Q2 | 20.59 Million USD | -1.47% |
2017 FY | 19.34 Million USD | 63.94% |
2017 Q3 | 16.85 Million USD | 15.89% |
2017 Q1 | 12.7 Million USD | 7.7% |
2017 Q4 | 19.34 Million USD | 14.73% |
2017 Q2 | 14.54 Million USD | 14.49% |
2016 Q2 | 11.36 Million USD | -7.78% |
2016 Q4 | 11.79 Million USD | -2.25% |
2016 Q1 | 12.32 Million USD | -6.92% |
2016 FY | 11.79 Million USD | -10.9% |
2016 Q3 | 12.07 Million USD | 6.19% |
2015 Q3 | 14.98 Million USD | -4.27% |
2015 Q1 | 15.61 Million USD | -0.91% |
2015 Q2 | 15.65 Million USD | 0.22% |
2015 FY | 13.24 Million USD | -15.99% |
2015 Q4 | 13.24 Million USD | -11.63% |
2014 FY | 15.76 Million USD | 37.74% |
2014 Q2 | 13.22 Million USD | 10.3% |
2014 Q3 | 14.84 Million USD | 12.2% |
2014 Q4 | 15.76 Million USD | 6.2% |
2014 Q1 | 11.99 Million USD | 4.81% |
2013 Q2 | 12.49 Million USD | -4.28% |
2013 Q3 | 12 Million USD | -3.98% |
2013 Q4 | 11.44 Million USD | -4.63% |
2013 FY | 11.44 Million USD | -10.3% |
2013 Q1 | 13.05 Million USD | 2.34% |
2012 Q4 | 12.75 Million USD | -0.68% |
2012 Q2 | 11.02 Million USD | 1.91% |
2012 Q3 | 12.84 Million USD | 16.51% |
2012 Q1 | 10.81 Million USD | 12.45% |
2012 FY | 12.75 Million USD | 32.61% |
2011 FY | 9.62 Million USD | 30.97% |
2011 Q3 | 9.44 Million USD | 15.97% |
2011 Q4 | 9.62 Million USD | 1.83% |
2011 Q1 | 7.74 Million USD | 5.5% |
2011 Q2 | 8.14 Million USD | 5.12% |
2010 Q1 | 9.3 Million USD | 5.25% |
2010 FY | 7.34 Million USD | -16.94% |
2010 Q4 | 7.34 Million USD | -7.94% |
2010 Q3 | 7.97 Million USD | -10.15% |
2010 Q2 | 8.88 Million USD | -4.6% |
2009 Q3 | 9.42 Million USD | 8.85% |
2009 Q1 | 9.91 Million USD | -7.35% |
2009 FY | 8.84 Million USD | -17.37% |
2009 Q4 | 8.84 Million USD | -6.21% |
2009 Q2 | 8.66 Million USD | -12.65% |
2008 Q1 | 9.92 Million USD | 5.52% |
2008 FY | 10.7 Million USD | 13.76% |
2008 Q2 | 10.28 Million USD | 3.59% |
2008 Q3 | 10.23 Million USD | -0.47% |
2008 Q4 | 10.7 Million USD | 4.56% |
2007 Q4 | 9.4 Million USD | 21.13% |
2007 FY | 9.4 Million USD | 70.02% |
2007 Q2 | 7.02 Million USD | 15.34% |
2007 Q1 | 6.08 Million USD | 10.02% |
2007 Q3 | 7.76 Million USD | 10.61% |
2006 FY | 5.53 Million USD | 34.07% |
2006 Q3 | 4.81 Million USD | -4.91% |
2006 Q1 | 4.65 Million USD | 12.87% |
2006 Q2 | 5.06 Million USD | 8.61% |
2006 Q4 | 5.53 Million USD | 15.01% |
2005 Q1 | 4.8 Million USD | -3.0% |
2005 FY | 4.12 Million USD | -16.64% |
2005 Q4 | 4.12 Million USD | -11.54% |
2005 Q3 | 4.66 Million USD | 13.06% |
2005 Q2 | 4.12 Million USD | -14.08% |
2004 FY | 4.95 Million USD | 23.69% |
2004 Q1 | 4.32 Million USD | 8.08% |
2004 Q3 | 4.66 Million USD | -2.08% |
2004 Q4 | 4.95 Million USD | 6.19% |
2004 Q2 | 4.76 Million USD | 10.07% |
2003 Q1 | 4.04 Million USD | -0.96% |
2003 Q3 | 4.01 Million USD | -3.78% |
2003 FY | 4 Million USD | -2.08% |
2003 Q2 | 4.17 Million USD | 2.99% |
2003 Q4 | 4 Million USD | -0.22% |
2002 Q3 | 4.58 Million USD | -8.14% |
2002 Q4 | 4.08 Million USD | -10.79% |
2002 Q1 | 4.88 Million USD | 9.88% |
2002 Q2 | 4.98 Million USD | 2.16% |
2002 FY | 4.08 Million USD | -8.02% |
2001 Q1 | 1.84 Million USD | 23.52% |
2001 Q2 | 2.16 Million USD | 17.43% |
2001 Q3 | 3.42 Million USD | 57.65% |
2001 Q4 | 4.44 Million USD | 29.96% |
2001 FY | 4.44 Million USD | 197.19% |
2000 Q2 | 1.24 Million USD | -5.19% |
2000 FY | 1.49 Million USD | -0.29% |
2000 Q4 | 1.49 Million USD | -15.76% |
2000 Q1 | 1.31 Million USD | -10.11% |
2000 Q3 | 1.77 Million USD | 42.3% |
1999 Q1 | 1.7 Million USD | 21.43% |
1999 Q3 | 1.5 Million USD | 0.0% |
1999 Q4 | 1.46 Million USD | -2.4% |
1999 Q2 | 1.5 Million USD | -11.76% |
1999 FY | 1.5 Million USD | 36.36% |
1998 Q2 | 1.1 Million USD | -8.33% |
1998 Q4 | 1.4 Million USD | 27.27% |
1998 FY | 1.1 Million USD | -15.38% |
1998 Q1 | 1.2 Million USD | -14.29% |
1998 Q3 | 1.1 Million USD | 0.0% |
1997 Q3 | 1.3 Million USD | -60.61% |
1997 FY | 1.3 Million USD | -83.12% |
1997 Q1 | 2.9 Million USD | -56.06% |
1997 Q2 | 3.3 Million USD | 13.79% |
1997 Q4 | 1.4 Million USD | 7.69% |
1996 Q4 | 6.6 Million USD | -14.29% |
1996 Q1 | 1.4 Million USD | -6.67% |
1996 Q2 | 1.3 Million USD | -7.14% |
1996 Q3 | 7.7 Million USD | 492.31% |
1996 FY | 7.7 Million USD | 450.0% |
1995 Q1 | 2.4 Million USD | 9.09% |
1995 Q2 | 1.6 Million USD | -33.33% |
1995 Q3 | 1.4 Million USD | -12.5% |
1995 Q4 | 1.5 Million USD | 7.14% |
1995 FY | 1.4 Million USD | -17.65% |
1994 FY | 1.7 Million USD | 70.0% |
1994 Q4 | 2.2 Million USD | 29.41% |
1994 Q3 | 1.7 Million USD | 0.0% |
1994 Q2 | 1.7 Million USD | 13.33% |
1994 Q1 | 1.5 Million USD | 36.36% |
1993 FY | 1 Million USD | 11.11% |
1993 Q1 | 700 Thousand USD | -12.5% |
1993 Q2 | 800 Thousand USD | 14.29% |
1993 Q3 | 1 Million USD | 25.0% |
1993 Q4 | 1.1 Million USD | 10.0% |
1992 Q2 | 900 Thousand USD | 12.5% |
1992 Q1 | 800 Thousand USD | -20.0% |
1992 FY | 900 Thousand USD | -18.18% |
1992 Q3 | 900 Thousand USD | 0.0% |
1992 Q4 | 800 Thousand USD | -11.11% |
1991 Q3 | 1.1 Million USD | 0.0% |
1991 Q2 | 1.1 Million USD | 10.0% |
1991 Q1 | 1 Million USD | 0.0% |
1991 FY | 1.1 Million USD | 37.5% |
1991 Q4 | 1 Million USD | -9.09% |
1990 Q2 | 400 Thousand USD | 100.0% |
1990 FY | 800 Thousand USD | 166.67% |
1990 Q3 | 800 Thousand USD | 100.0% |
1990 Q1 | 200 Thousand USD | -33.33% |
1990 Q4 | 1 Million USD | 25.0% |
1989 FY | 300 Thousand USD | 0.0% |
1989 Q4 | 300 Thousand USD | 0.0% |
1989 Q2 | 300 Thousand USD | 0.0% |
1989 Q3 | 300 Thousand USD | 0.0% |
Name | Inventory | Inventory Difference |
---|---|---|
Akoya Biosciences, Inc. | 17.87 Million USD | -166.342% |
AngioDynamics, Inc. | 60.61 Million USD | 21.45% |
AtriCure, Inc. | 67.89 Million USD | 29.873% |
Avinger, Inc. | 5.29 Million USD | -798.716% |
Azenta, Inc. | 128.19 Million USD | 62.859% |
BioLife Solutions, Inc. | 43.45 Million USD | -9.568% |
The Cooper Companies, Inc. | 735.6 Million USD | 93.527% |
Daxor Corporation | - USD | -Infinity% |
Ekso Bionics Holdings, Inc. | 5.05 Million USD | -842.851% |
Femasys Inc. | 667.11 Thousand USD | -7037.268% |
GlucoTrack, Inc. | - USD | -Infinity% |
Harvard Bioscience, Inc. | 24.71 Million USD | -92.644% |
Hologic, Inc. | 679.8 Million USD | 92.996% |
ICU Medical, Inc. | 709.36 Million USD | 93.288% |
Intuitive Surgical, Inc. | 1.22 Billion USD | 96.099% |
KORU Medical Systems, Inc. | 3.48 Million USD | -1267.707% |
LeMaitre Vascular, Inc. | 52.33 Million USD | 9.017% |
Innovative Eyewear, Inc. | 856.75 Thousand USD | -5457.455% |
Innovative Eyewear, Inc. | 856.75 Thousand USD | -5457.455% |
Masimo Corporation | 545 Million USD | 91.263% |
Microbot Medical Inc. | - USD | -Infinity% |
Meihua International Medical Technologies Co., Ltd. | 1.61 Million USD | -2844.179% |
Merit Medical Systems, Inc. | 303.87 Million USD | 84.331% |
Nephros, Inc. | 2.47 Million USD | -1827.692% |
NovoCure Limited | 38.15 Million USD | -24.801% |
NEXGEL, Inc. | 1.31 Million USD | -3509.856% |
NEXGEL, Inc. | 1.31 Million USD | -3509.856% |
Singular Genomics Systems, Inc. | 13.57 Million USD | -250.825% |
Pro-Dex, Inc. | 15.26 Million USD | -211.834% |
Pulse Biosciences, Inc. | - USD | -Infinity% |
Predictive Oncology Inc. | 494.37 Thousand USD | -9531.17% |
Precision Optics Corporation, Inc. | 2.86 Million USD | -1560.123% |
QuidelOrtho Corporation | 577.8 Million USD | 91.759% |
Repligen Corporation | 202.32 Million USD | 76.466% |
Sanara MedTech Inc. | 4.71 Million USD | -909.299% |
STAAR Surgical Company | 35.13 Million USD | -35.537% |
Sharps Technology, Inc. | 1.7 Million USD | -2685.854% |
Utah Medical Products, Inc. | 9.58 Million USD | -396.911% |
DENTSPLY SIRONA Inc. | 624 Million USD | 92.37% |
Jin Medical International Ltd. | 5.05 Million USD | -842.266% |